Cowealth Medical China Co.,Ltd.

SHSE:603122 Voorraadrapport

Marktkapitalisatie: CN¥2.8b

Cowealth Medical ChinaLtd Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Qiongzhi Wang

Algemeen directeur

CN¥5.1m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO5.6yrs
Eigendom CEO0.02%
Management gemiddelde ambtstermijn5.6yrs
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

There's Reason For Concern Over Cowealth Medical China Co.,Ltd.'s (SHSE:603122) Massive 30% Price Jump

Nov 12
There's Reason For Concern Over Cowealth Medical China Co.,Ltd.'s (SHSE:603122) Massive 30% Price Jump

Cowealth Medical China Co.,Ltd.'s (SHSE:603122) Shareholders Might Be Looking For Exit

Jul 23
Cowealth Medical China Co.,Ltd.'s (SHSE:603122) Shareholders Might Be Looking For Exit

Cowealth Medical ChinaLtd (SHSE:603122) Could Be Struggling To Allocate Capital

Mar 18
Cowealth Medical ChinaLtd (SHSE:603122) Could Be Struggling To Allocate Capital

CEO

Qiongzhi Wang (67 yo)

5.6yrs

Tenure

CN¥5,142,791

Compensatie

Ms. Qiongzhi Wang is GM & Director of Cowealth Medical China Co.,Ltd. from April 19, 2019.

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Qiongzhi Wang
GM & Director5.6yrsCN¥5.14m0.023%
CN¥ 640.6k
Chen Zhang
Accounting Supervisor5.6yrsCN¥1.04mgeen gegevens
Ye Chen
Deputy GM & Secretary of the Board5.6yrsCN¥1.21mgeen gegevens

5.6yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 603122 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.6 jaar).